Close Menu

NEW YORK – Meridian Bioscience announced Monday its Curian analyzer and Curian HpSA assay received clearance from the US Food and Drug Administration. 

The analyzer and assay detect Helicobacter pylori antigens in stool samples using immunofluorescent technology and are intended to help clinicians diagnose the infection. They can also be used to confirm successful treatment of H. pylori, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.